48 results on '"Van, Gwyneth"'
Search Results
2. RANK Is the Intrinsic Hematopoietic Cell Surface Receptor That Controls Osteoclastogenesis and Regulation of Bone Mass and Calcium Metabolism
3. The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts
4. Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats
5. Antagonism of Ang-Tie2 and Dll4-Notch signaling has opposing effects on tumor endothelial cell proliferation, evidenced by a new flow cytometry method
6. Most purported antibodies to the human granulocyte colony-stimulating factor receptor are not specific
7. Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors
8. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
9. T-cell co-stimulation through B7RP-1 and ICOS
10. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
11. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
12. The Candidate Neuroprotective Agent Artemin Induces Autonomic Neural Dysplasia without Preventing Peripheral Nerve Dysfunction
13. Inhibition of Interleukin-1 but Not Tumor Necrosis Factor Suppresses Neovascularization in Rat Models of Corneal Angiogenesis and Adjuvant Arthritis
14. Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis
15. Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production
16. Myofibroblast and α1(III) collagen expression in experimental tubulointerstitial nephritis
17. Leukemia inhibitory factor ameliorates experimental anti-GBM Ab glomerulonephritis
18. Heparin attenuates bleomycin but not silica-induced pulmonary fibrosis in mice: possible relationship with involvement of myofibroblasts in bleomycin, and fibroblasts in silica-induced fibrosis
19. A novel Notch ligand, Dll4, induces T-cell leukemia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer
20. Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in Vivo
21. Discovery and Structure-Guided Optimization of Diarylmethanesulfonamide Disrupters of Glucokinase–Glucokinase Regulatory Protein (GK–GKRP) Binding: Strategic Use of a N → S (nN → σ*S–X) Interaction for Conformational Constraint
22. Small Molecule Disruptors of the Glucokinase–Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational Analysis
23. Correction to Small Molecule Disruptors of the Glucokinase–Glucokinase Regulatory Protein Interaction: 1. Discovery of a Novel Tool Compound for in Vivo Proof-of-Concept
24. Small Molecule Disruptors of the Glucokinase–Glucokinase Regulatory Protein Interaction: 1. Discovery of a Novel Tool Compound for in Vivo Proof-of-Concept
25. Small Molecule Disruptors of the Glucokinase–Glucokinase Regulatory Protein Interaction: 2. Leveraging Structure-Based Drug Design to Identify Analogues with Improved Pharmacokinetic Profiles
26. Epo Receptors Are Not Detectable in Primary Human Tumor Tissue Samples
27. Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptor
28. Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock‐In Mice That Express Chimeric (Murine/Human) RANKL
29. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFα or anti-IL-1 therapies
30. Response to Letter Regarding Article, “Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr (−/−) Mice”
31. Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis inldlr (−/−)Mice
32. Continuous RANKL Inhibition in Osteoprotegerin Transgenic Mice and Rats Suppresses Bone Resorption without Impairing Lymphorganogenesis or Functional Immune Responses
33. Anti-Epo receptor antibodies do not predict Epo receptor expression
34. Is EPO Receptor Expressed in Human Tumor Cells?.
35. A novel chordin-like BMP inhibitor, CHL2, expressed preferentially in chondrocytes of developing cartilage and osteoarthritic joint cartilage
36. Expression profiling of Epo receptor in non-hematopoietic tissues: implications for a direct effect of rHuEpo on cardiac cells
37. Potent activity of soluble B7RP-1-Fc in therapy of murine tumors in syngeneic hosts
38. Regulatory Effects of Novel Neurotrophin-1/B Cell-Stimulating Factor-3 (Cardiotrophin-Like Cytokine) on B Cell Function
39. Osteoprotegerin inhibits tumor-induced osteoclastogenesis and bone tumor growth in osteopetrotic mice
40. Small Molecule Disruptorsof the Glucokinase–GlucokinaseRegulatory Protein Interaction: 1. Discovery of a Novel Tool Compoundfor in Vivo Proof-of-Concept.
41. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors
42. Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors
43. Monoclonal antibody to MALA-2 (ICAM-1) reduces acute autoimmune nephritis in kdkd mice
44. Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice.
45. Potent activity of soluble B7RP-1-Fc in therapy of murine tumors in syngeneic hosts.
46. A novel Notch ligand, Dll4,induces T-cell leukemia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer
47. Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitroand in Vivo
48. Correction to Small MoleculeDisruptors of the Glucokinase–Glucokinase Regulatory ProteinInteraction: 1. Discovery of a Novel Tool Compound for in Vivo Proof-of-Concept.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.